Connecting PBC Tenants and the Life-science Community
Pasadena Bio recognizes our role in assisting biotechnology start-up companies to achieve success by reaching beyond the wetlab. Our incubator tenants to have access to experts in a diverse range of fields to help ensure the future viability of these important business ventures. We also host occasional "Lunch and Learn" seminars for the education and networking needs of our tenants - see our Events Calendar for upcoming seminars.
Mr. Johnston conducts workshops in data analysis, bioinformatics, and data management. He also provides consulting services for biotech companies.
CEO, Ms. Siegal is a business development and new product marketing consultant for the biotechnology industry. She currently serves as a principal advisor to the NIH Commercialization Access Program for SBIR grant recipients. Ms. Siegal has worked with numerous biotechnology companies in evaluating new products, crafting business plans and establishing strategic alliances. She has over two decades of industry experience including executive positions at Xencor, Cell-Matrix and Alpha Therapeutic Corporation.
Kirstin Torguson and Associates provide customized research administration services to small businesses, non-profits and educational and research institutions. They are well versed in all phases of the grants lifecycle from pre-award tasks to post-award compliance. They specialize in federal grant proposal submissions and grant management.
Molly Schmid, Ph.D., TriTech SBDC
Molly Schmid provides SBIR consulting to qualified small businesses through the TriTech SBDC program (www.tritechsbdc.org). TriTech was awarded the 2017 California FAST grant from the SBA, and can offer these services to you for no-cost. Molly has a significant number of years experience as an NIH reviewer of SBIR proposals, and has counseled clients who have been awarded SBIR funding from NIH, NSF, DOD, and DoEd.
LCS offers complete writing and editing services, including but not limited to grant writing, manuscript drafting, data preparation. copy editing, substantive editing, scientific review, journal formatting, and more. No job is too small, and PBC tenants will receive a 20% discount.
Insurance and risk management consulting for small and start up tech and life science firms to cover liabilities as they develop their technology and product. Special coverage and pricing through SoCalBio’s Program for liability, property, worker’s comp, director’s & officer’s liability, employee benefits.
Shawn is an intellectual property partner with a successful track record over nearly two decades of representing emerging and established companies in litigation of intellectual property cases. He also represents clients inter partes review of proceedings before the Patent Trial and Appeal Board of the US Patent and Trademark Office. For more information on Shawn, click here.
Rick has extensive experience in tax-exempt and taxable government financings, as bond counsel for many California agencies and as underwriter’s counsel, borrower’s counsel, and liquidity/credit provider’s counsel, Mr. Jones has experience in mergers and acquisitions and in corporate equity financings. Rick is the founding partner of the Los Angeles office of Nixon Peabody LLP, a global law firm specializing in business transactions and litigation.
George Colanders, Senior Counsel, Perkins Coie
George is with the Corporate practice and Emerging Companies & Venture Capital practice. He acts as outside general counsel for clients in many areas including Corporate governance, entity formation and capital structuring, licensing agreements, employment and compensation matters, equity financings and M&A transactions.
Ray has broad based knowledge in drug manufacturing operations including quality assurance, manufacturing process development, tech transfer, facility engineering and global supply chain management. His technology experience include large and small molecule drugs as well as medical devices.
PAREXEL is a leading Clinical Research Organization providing comprehensive drug development capabilities worldwide. Its global regulatory expertise, Phase I-IV clinical research services, integrated eClinical technologies, and advanced commercialization services all work together to move through the development process very smoothly and cost-effectively from beginning to end.